Incidence of Infection and Mortality by COVID-19 in Specialists

Incidence of Infection and Mortality by COVID-19 in Specialists in Mexico: A Cross-sectional Study

In this current study the researchers aim to identify the total number of infections and deaths due to COVID-19 and distinguish which are the risk factors most related to COVID-19 infections and deaths in medical personnel in Mexico.

Study Overview

• Status: Completed
• Conditions: Covid19; Death; Health Care Associated Infection; Infection, Coronavirus
• Intervention / Treatment: Behavioral: Survey

• Study Type: Observational
• Enrollment (Actual): 400

Contacts and Locations

Study Locations

• Mexico
  • Jalisco
    • Guadalajara, Jalisco, Mexico, 44329
      • Centro Médico Nacional de Occidente

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

Active physicians and medical students who have had contact with COVID-19 patients.

Description

Inclusion Criteria:

• Active physicians and medical students who have had contact with patients infected by COVID-19
• Active physicians and medical students who have been infected by COVID-19

Exclusion Criteria:

• Members of the general population
• Inactive physicians or medical students
• Incomplete surveys

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Incidence of mortality in physicians due to COVID-19	An online survey made by the authors was used, which is comprised of a total of 48 questions where different types of information are distinguished regarding the participant who is answering if during the pandemic they refers to whether they know doctors in the same specialty or others who have died from COVID-19 infection.	Baseline
Incidence of infection in physicians due to COVID-19	An online survey made by the authors was used, which is comprised of a total of 48 questions where different types of information are distinguished regarding the participant who is answering if during the pandemic they have been in contact with patients suspected or confirmed of COVID-19 infection if they have been infected by COVID-19 and the outcome of this infection.	Baseline

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Physician´s Risk factors of contagion such as age, gender, medical degree, and comorbidities	An online survey made by the authors was used, which is comprised of a total of 48 questions where different types of information are distinguished regarding the participant who is answering it such as age, gender, medical degree, comorbidities, and the association with the severity of the infection by COVID-19.	Baseline

Collaborators and Investigators

• Sponsor: Instituto Mexicano del Seguro Social

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2021
• Primary Completion (Actual): May 30, 2021
• Study Completion (Actual): June 1, 2021

Study Registration Dates

• First Submitted: March 30, 2021
• First Submitted That Met QC Criteria: March 30, 2021
• First Posted (Actual): April 1, 2021

Study Record Updates

• Last Update Posted (Actual): October 2, 2023
• Last Update Submitted That Met QC Criteria: September 29, 2023
• Last Verified: September 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; Disease Attributes; Iatrogenic Disease; COVID-19; Coronavirus Infections; Infections; Communicable Diseases; Cross Infection
• Other Study ID Numbers: Mortality Physicians

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No